Melaxib (Lactulose, Vaseline, Liquid Paraffin)

Lactulose is a synthetic disaccharide that reaches the colon unchanged, where bacterial enzymes break it down into short‑chain fatty acids. These acids increase the osmotic pressure inside the intestinal lumen, drawing water into the bowel, softening stool and stimulating peristalsis. The added vaseline and liquid paraffin coat the stool, reducing friction and further easing passage.

The dose of Melaxib is individualized by a qualified prescriber based on the patient’s condition, age, renal function and response to therapy. Healthcare professionals determine the volume of oral solution to be taken, the frequency of administration, and any necessary adjustments during treatment.

Safety data for Melaxib in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any possible risk to the fetus or infant. Pregnant or nursing women should discuss use with their obstetrician or healthcare provider before starting therapy.

To order Melaxib, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify institutional credentials, then provide pricing, availability, shipping details and any required import documentation.

Melaxib combines an osmotic agent (lactulose) with lubricating agents (vaseline and liquid paraffin), offering both stool softening and increased water content. Compared with polyethylene glycol‑based laxatives, Melaxib may provide a milder onset and added benefit for hepatic encephalopathy, whereas PEG products focus solely on osmotic action without the lubricating component.

Melaxib should be stored at ambient temperature, preferably below 25 °C, in its original container to protect it from moisture and light. Keep the bottle tightly closed when not in use and keep out of reach of children.

Melaxib is taken orally as a measured liquid solution. The prescriber will specify the exact volume to be consumed, usually using a calibrated dosing cup or syringe. It can be taken with or without food, and the dose may be adjusted based on clinical response.

The most serious risks include severe dehydration, electrolyte disturbances such as low potassium or sodium, and rare allergic reactions that may present as rash, swelling or breathing difficulty. Patients experiencing these symptoms should seek immediate medical attention.

Melaxib is contraindicated in individuals with known or suspected intestinal obstruction, perforation, or severe inflammatory bowel disease. Patients with hypersensitivity to any of its components (lactulose, vaseline, liquid paraffin) should also avoid its use. A healthcare professional should evaluate suitability before starting therapy.